Related Topics
Efforts to increase HPV vaccine use are cost effective
Three types of interventions aimed at increasing human papillomavirus (HPV) vaccine coverage are all cost-effective.
‘A terrific first start’
Barry Bloom offers context about the news that two experimental vaccines appear to confer a high level of protection from the coronavirus.
Op-ed: Public health leaders can build public support for a COVID-19 vaccine
With recent surveys suggesting that many Americans may be reluctant to take a COVID-19 vaccine once it’s available, it will be important for public health leaders to reduce fear and build public support for a vaccine.
Pandemic response so far—and what may lie ahead
Epidemiologist Marc Lipsitch discussed a range of topics related to the coronavirus pandemic in a half-hour interview on the podcast “Deep Background with Noah Feldman.”
New tool can help guide COVID-19 vaccine distribution
A new data-driven tool will help state and county decision makers in the U.S. plan for the distribution of coronavirus vaccines to priority populations.
Expert: Coronavirus vaccine approval could come by end of 2020
The odds are “reasonably high” that a coronavirus vaccine will be approved before the end of the year, according to Harvard Chan School's Howard Koh.
Viewpoint: Prioritizing racial minorities for COVID-19 vaccines
An op-ed co-authored by Dean Michelle Williams addresses the issue of race and vaccine allocation in the U.S.
Op-ed: A call to build trust in COVID-19 vaccination
Howard Koh of Harvard Chan School outlined five ways for political leaders to build trust in a coronavirus vaccine.
Frontlines Fall 2020
Quick updates about the latest public health news from across the School and beyond.
The Connected Crisis
The COVID-19 pandemic has inspired new research directions across the School
